ReviewFrontiers in microbiology2018

Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

Christopher Vinnard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.